The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,425.00
Bid: 2,370.00
Ask: 2,385.00
Change: 50.00 (2.11%)
Spread: 15.00 (0.633%)
Open: 2,340.00
High: 2,425.00
Low: 2,340.00
Prev. Close: 2,375.00
OXIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal

18 Nov 2016 07:00

RNS Number : 5211P
Oxford Instruments PLC
18 November 2016
 

Release date: 18 November 2016

Oxford Instruments plc

Disposal of Oxford Instruments Superconducting Wire LLC ("OST")

 

Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, today announces the disposal of Oxford Instruments Superconducting Wire LLC ("OST") to Bruker Energy and Supercon Technologies Inc ("BEST"), a subsidiary of Bruker Corporation, for a consideration of $17.5 million, payable in cash. In the transaction, BEST has acquired the entire share capital of OST from Oxford Instruments.

 

OST supplies world-leading superconducting wire for use in MRI scanners and other medical and scientific applications; it is located in Carteret, New Jersey, USA. The business was previously part of Oxford Instruments' Industrial Products division.

 

In the year ended 31 March 2016, OST had revenues of £42.4 million and achieved an operating profit of £3.4 million. In the six months to 30 September 2016, OST had revenues of £19.1 million and achieved an operating profit of £1.1 million. The gross assets of OST at 31 March 2016 were £19.0 million.

Oxford Instruments has previously reported challenges within the superconducting wire markets due primarily to pricing pressures exerted by the MRI system manufacturers and reduced demand for wire from OEM customers. The disposal represents a further step in the Group's strategy of actively managing its portfolio.

Ian Barkshire, Chief Executive of Oxford Instruments said "After a comprehensive review of our portfolio, the Board has determined that our Superconducting Wire business is no longer core to the Group's long-term strategic vision. The divestment will allow increased focus across the Group on our chosen market segments and the cash proceeds will enable us to reduce our net debt, in line with our strategy to deliver enhanced shareholder value.

"OST is a high quality business and we believe that as part of BEST, it will benefit from the realisation of synergies and the scale of BEST's expertise in low-temperature superconductors. This will ensure that the business continues to provide customers with the highest quality products and fosters the exceptional skills of its talented workforce."

 

Enquiries:

 

Oxford Instruments plc Tel: 01865 393200

Ian Barkshire, Chief Executive

Gavin Hill, Group Finance Director

 

MHP Communications Tel: 020 3128 8100

Rachel Hirst/Jamie Ricketts

 

 

- Ends -

Issued for and on behalf of Oxford Instruments plc

Notes to Editors  

 

About Oxford Instruments plc

Oxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. Innovation has been the driving force behind Oxford Instruments' growth and success for over 50 years, and its strategy is to effect the successful commercialisation of these ideas by bringing them to market in a timely and customer-focused fashion. 

 

The first technology business to be spun out from Oxford University, Oxford Instruments is now a global company and is listed on the London Stock Exchange (OXIG). Its objective is to be the leading provider of new generation tools and systems for the research and industrial sectors with a focus on nanotechnology. Its key market sectors include nano-fabrication and nano-materials. The company's strategy is to expand the business into the life sciences arena, where nanotechnology and biotechnology intersect.

 

This involves the combination of core technologies in areas such as low temperature and high magnetic field environments; Nuclear Magnetic Resonance; X-ray, electron, laser and optical based metrology; atomic force microscopy; optical imaging; advanced growth, deposition and etching.

 

Oxford Instruments aims to pursue responsible development and deeper understanding of our world through science and technology. Its products, expertise, and ideas address global issues such as energy, environment, security and health.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISDXBDBDXBBGLR
Date   Source Headline
2nd Mar 202012:06 pmPRNTotal Voting Rights
2nd Mar 202012:02 pmRNSPrice Monitoring Extension
27th Feb 202012:07 pmRNSSecond Price Monitoring Extn
27th Feb 202012:02 pmRNSPrice Monitoring Extension
24th Feb 20207:00 amRNSDisposal of OI Healthcare business in the US
10th Feb 20201:49 pmPRNDirector/PDMR Shareholding
3rd Feb 202012:41 pmPRNTotal Voting Rights
29th Jan 20207:00 amRNSSale of Minority Share in Scienta Omicron
23rd Jan 202010:52 amPRNAdditional Listing
13th Jan 20209:55 amPRNDirector/PDMR Shareholding
10th Jan 202012:02 pmRNSPrice Monitoring Extension
9th Jan 202010:42 amPRNTotal Voting Rights
9th Jan 20209:41 amPRNBlocklisting - Interim Review
3rd Jan 20208:36 amPRNHolding(s) in Company
11th Dec 20194:03 pmPRNDirector/PDMR Shareholding
2nd Dec 20192:54 pmPRNTotal Voting Rights
12th Nov 201912:49 pmPRNDirector/PDMR Shareholding
12th Nov 20197:00 amRNSHalf-year Report
11th Oct 201912:02 pmRNSPrice Monitoring Extension
10th Oct 20194:34 pmPRNDirector/PDMR Shareholding
3rd Oct 201911:00 amPRNTotal Voting Rights
11th Sep 20193:30 pmPRNDirector/PDMR Shareholding
11th Sep 201912:12 pmPRNResult of AGM
11th Sep 201910:50 amPRNDirector/PDMR Shareholding
10th Sep 20197:00 amRNSChairman's AGM Statement 2019
29th Aug 201912:07 pmRNSSecond Price Monitoring Extn
29th Aug 201912:02 pmRNSPrice Monitoring Extension
22nd Aug 20191:24 pmPRNHolding(s) in Company
13th Aug 201910:26 amPRNDirector/PDMR Shareholding
15th Jul 20194:26 pmPRNDirector/PDMR Shareholding
11th Jul 201911:49 amPRNDirector/PDMR Shareholding
1st Jul 201911:07 amPRNBlocklisting - Interim Review
27th Jun 20195:01 pmPRNHolding(s) in Company
26th Jun 20195:30 pmRNSRPC Group
11th Jun 20191:02 pmPRNDirector/PDMR Shareholding
11th Jun 20197:00 amRNSFinal Results
30th May 20191:18 pmPRNHolding(s) in Company
13th May 201910:27 amPRNDirector/PDMR Shareholding
11th Apr 201912:00 pmPRNDirector/PDMR Shareholding
11th Apr 20197:00 amRNSTrading Statement
22nd Mar 20197:00 amRNSContract win
11th Mar 20191:40 pmPRNDirector/PDMR Shareholding
12th Feb 20191:32 pmPRNDirector/PDMR Shareholding
1st Feb 20199:56 amPRNDirector Declaration
15th Jan 201910:28 amPRNAdditional Listing
14th Jan 20194:01 pmPRNBlocklisting - Interim Review
11th Jan 201910:28 amPRNDirector/PDMR Shareholding
3rd Jan 201912:26 pmPRNDirector Declaration
2nd Jan 201911:33 amPRNHolding(s) in Company
17th Dec 20181:22 pmPRNHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.